News
Welcome to our news page. Here, you can learn more about the latest events and ATMP in Flemingsberg.
Matti Sällberg: We’re going to see an explosion of ATMPs coming to the benefit of patients
Advanced Therapy Medicinal Products (ATMPs) are revolutionizing healthcare, and in Stockholm and Flemingsberg, we're experts in this field. Listen to Matti Sällberg, professor and dean at Karolinska Institutet South, as he shares insights on how we're translating these scientific advancements from the lab to the clinic and changing lives. A film made by Stockholm Business Region.
“We wanted to become part of the ATMP cluster that already existed in the area.”
For the past ten years, NextCell Pharma has been developing cell therapies for autoimmune and inflammatory diseases, operating Sweden's largest stem cell biobank through its subsidiary Cellaviva and conducting five clinical trials. Mathias Svahn, CEO and co-founder, tells us about their success story and how they became one of the biggest ATMP companies in Flemingsberg.
Trust the (cell manufacturing) Process in Flemingsberg
Earlier this year we hosted the most meaningful ATMP event of the spring, in collaboration with Miltenyi Biotec and the Karolinska ATMP Center, Karolinska University Hospital and Karolinska Institutet. We gathered over 120 participants, all sharing a vision of creating momentum to accelerate access to ATMPs in the Nordics.
Nikola Vojnovic: I don’t think it’s far-fetched that the new cancer medicine comes from KI
Flemingsberg has been a pioneer in cell therapy in Sweden, dating back to as late as 1996. To highlight this and launch the new ATMP Flemingsberg initiative, Miltenyi Biotec and the Flemingsberg Science Foundation welcome you to the most important ATMP event of the spring: Trust the (cell manufacturing) process, on March 21 at Campus Flemingsberg.
Innovate UK x ATMP Flemingsberg: Collaborations, Inspiration, and Networking
At the beginning of the year, we had the privilege of welcoming a delegation from England, with representatives from Innovate UK and eleven ATMP (Advanced Therapy Medicinal Products) companies. This marks the beginning of a significant partnership with great potential to ultimately cure diseases that were previously incurable.
Cellaviva: improving lives through stem cell technology
In a world grappling with complex diseases, Cellaviva emerges as a ray of hope. Founded by Karolinska Institutet researchers, Cellaviva believes stem cells hold the key to transforming medical treatment. At its heart, Cellaviva is a biobank, helping expectant parents store umbilical cord stem cells for future medical needs, ushering in a new era of personalized care.
